Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.
Ratings
4.8 / 5
6 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Leonard S. Schleifer,M.D.,PhD$99.5B
Market Cap • 24/04/20241988
(há 36 anos)
1991
(33 years ago)
NASDAQ
ListagemS&P500 Participant
Index Composite • 2024
Tarrytown
Sede • New York11.851
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
REGNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.